James Mond
2019
In 2019, James Mond earned a total compensation of $1.2M as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $207,500 |
|---|---|
| Option Awards | $380,429 |
| Salary | $415,000 |
| Other | $234,493 |
| Total | $1,237,422 |
Mond received $415K in salary, accounting for 34% of the total pay in 2019.
Mond also received $207.5K in bonus, $380.4K in option awards and $234.5K in other compensation.
Rankings
In 2019, James Mond's compensation ranked 8,273rd out of 13,971 executives tracked by ExecPay. In other words, Mond earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,273 out of 13,971 | 41st |
Division Manufacturing | 3,269 out of 5,701 | 43rd |
Major group Chemicals And Allied Products | 1,237 out of 2,200 | 44th |
Industry group Drugs | 1,051 out of 1,886 | 44th |
Industry Biological Products, Except Diagnostic Substances | 238 out of 389 | 39th |
Source: SEC filing on April 29, 2020.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2019.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019